Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Drugs & Aging

Issue 3/2011

Content (7 Articles)

Review Article

Optimal Pharmacotherapeutic Management of Chronic Lymphocytic Leukaemia

Valentin Goede, Michael Hallek

Review Article

Use of Low-Molecular-Weight Heparins and New Anticoagulants in Elderly Patients with Renal Impairment

Meyer Michel Samama

Original Research Article

Effects of Anticholinergic Drugs on Verbal Episodic Memory Function in the Elderly

Marie-Pierre Fortin, Isabelle Rouch, Virginie Dauphinot, Claire Gédéon, Stella Genthon, Marc Bonnefoy, Pierre Krolak-Salmon

Original Research Article

Effect of Memantine on Resting State Default Mode Network Activity in Alzheimer’s Disease

Marco Lorenzi, Alberto Beltramello, Nicola B. Mercuri, Elisa Canu, Giada Zoccatelli, Francesca B. Pizzini, Franco Alessandrini, Maria Cotelli, Sandra Rosini, Daniela Costardi, Carlo Caltagirone, Giovanni B. Frisoni

Original Research Article

Polypharmacy, Aging and Potential Drug-Drug Interactions in Outpatients in Taiwan

Chen-Fang Lin, Chun-Yu Wang, Chyi-Huey Bai

Original Research Article

Potentially Inappropriate Medication Use Among Finnish Non-Institutionalized People Aged ≥65 Years

Saija Leikola, Maarit Dimitrow, Alan Lyles, Kaisu Pitkälä, Marja Airaksinen

Adis Drug Profile

Naproxen/Esomeprazole Fixed-Dose Combination

Sohita Dhillon

Feb 11
Issue: 2/2011
Apr 11
Issue: 4/2011

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits